 The Journal of Life Sciences is a new publication for our industry's thought leaders and decision makers. It focuses on the most important topics in science, business, politics, and society, providing readers with high-level overview, debate and analysis. The Journal is a joint venture between the California Healthcare Institute (CHI) and Burrill & Company.
We have assembled a world-class editorial team and advisory board to ensure that the quality of thought and writing meets the highest standard. Our vision is to make The Journal of Life Sciences the forum of choice for the larger biomedical community: scientists, business executives, policymakers at various levels of government. To achieve this, we will cover the key stories in biotech, pharmaceuticals, medical devices, diagnostics, and academic research, but also to explain these developments and their implications in context.
Click here for details. |
